Cargando…
Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies
OBJECTIVE: To investigate the effects of adjunct ketamine treatment on chronic treatment‐resistant schizophrenia patients with treatment‐resistant depressive symptoms (CTRS‐TRD patients), including alterations in brain function. METHODS: Intravenous ketamine (0.5 mg/kg body weight) was administered...
Autores principales: | Zhuo, Chuanjun, Lin, Xiaodong, Tian, Hongjun, Liu, Sha, Bian, Haiman, Chen, Ce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218248/ https://www.ncbi.nlm.nih.gov/pubmed/32174025 http://dx.doi.org/10.1002/brb3.1600 |
Ejemplares similares
-
Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2020) -
Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow‐up study
por: Zhuo, Chuanjun, et al.
Publicado: (2020) -
Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment‐resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans
por: Zhuo, Chuanjun, et al.
Publicado: (2019) -
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2023) -
Unsatisfactory Laws
Publicado: (1890)